22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
Ryan Allway May 18th, 2022 News, Top News Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMO Consistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for Consumers Acquisition Immediately Accretive; Will Double 22nd Century Revenue BUFFALO, N.Y., May 18, 2022 (GLOBE NEWSWIRE) — 22nd... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )